Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+115.8%
5Y CAGR+6.2%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+115.8%/yr
vs -58.2%/yr prior
5Y CAGR
+6.2%/yr
Recent acceleration
Acceleration
+174.0pp
Accelerating
Percentile
P96
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 46.14% |
| Q3 2025 | -7.25% |
| Q2 2025 | 3.30% |
| Q1 2025 | 9.72% |
| Q4 2024 | 0.54% |
| Q3 2024 | 0.78% |
| Q2 2024 | 5.33% |
| Q1 2024 | -3.38% |
| Q4 2023 | 19.13% |
| Q3 2023 | -2.90% |
| Q2 2023 | 6.06% |
| Q1 2023 | 2.10% |
| Q4 2022 | 4.59% |
| Q3 2022 | -1.24% |
| Q2 2022 | 19.34% |
| Q1 2022 | -4.96% |
| Q4 2021 | 11.93% |
| Q3 2021 | 6.42% |
| Q2 2021 | 4.23% |
| Q1 2021 | -3.03% |
| Q4 2020 | 34.12% |
| Q3 2020 | 15.14% |
| Q2 2020 | -10.97% |
| Q1 2020 | -26.89% |
| Q4 2019 | 21.07% |
| Q3 2019 | 78.47% |
| Q2 2019 | 40.55% |
| Q1 2019 | 0.00% |